TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CPR Stock 12 Month Forecast
Average Price Target
€7.41
▲(29.32% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Davide Campari-Milano SpA in the last 3 months. The average price target is €7.41 with a high forecast of €11.00 and a low forecast of €5.13. The average price target represents a 29.32% change from the last price of €5.73.
Davide Campari-Milano Spa (CPR:IM) PT Lowered to EUR8.50 at StifelStifel analyst Cedric Lecasble lowered the price target on Davide Campari-Milano Spa (CPR:IM) to EUR8.50 (from EUR9.00) while maintaining a Buy rating.
BofA Securities Downgrades Davide Campari-Milano Spa (CPR:IM) to NeutralBofA Securities analyst Andrea Pistacchi downgraded Davide Campari-Milano Spa (CPR:IM) from Buy to Neutral with a price target of EUR6.30 (from EUR8.50).
Davide Campari-Milano Spa (CPR:IM) PT Lowered to EUR8.50 at StifelStifel analyst Cedric Lecasble lowered the price target on Davide Campari-Milano Spa (CPR:IM) to EUR8.50 (from EUR9.00) while maintaining a Buy rating.
BofA Securities Downgrades Davide Campari-Milano Spa (CPR:IM) to NeutralBofA Securities analyst Andrea Pistacchi downgraded Davide Campari-Milano Spa (CPR:IM) from Buy to Neutral with a price target of EUR6.30 (from EUR8.50).
Stocks with the Highest Top Analyst Consensus in the Consumer Defensive Sector
trades and holding each position for 1 Month would result in 84.62% of your transactions generating a profit, with an average return of +5.47% per trade.
trades and holding each position for 3 Months would result in 61.54% of your transactions generating a profit, with an average return of +2.38% per trade.
Copying Javier Gonzalez Lastra's trades and holding each position for 1 Year would result in 73.33% of your transactions generating a profit, with an average return of +14.73% per trade.
trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +7.18% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CPR Analyst Recommendation Trends
Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
2
2
1
2
1
Buy
5
4
4
5
5
Hold
16
16
20
18
12
Sell
1
1
1
0
0
Strong Sell
0
0
0
0
0
total
24
23
26
25
18
In the current month, CPR has received 6Buy Ratings, 12Hold Ratings, and 0Sell Ratings. CPR average Analyst price target in the past 3 months is 7.41.
Each month's total comprises the sum of three months' worth of ratings.
CPR Financial Forecast
CPR Earnings Forecast
Next quarter’s earnings estimate for CPR is €0.28 with a range of €0.28 to €0.28. The previous quarter’s EPS was €0.00. CPR beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.98% of the time in the same period. In the last calendar year CPR has Performed in-line its overall industry.
Next quarter’s earnings estimate for CPR is €0.28 with a range of €0.28 to €0.28. The previous quarter’s EPS was €0.00. CPR beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.98% of the time in the same period. In the last calendar year CPR has Performed in-line its overall industry.
CPR Sales Forecast
Next quarter’s sales forecast for CPR is €795.38M with a range of €761.62M to €850.10M. The previous quarter’s sales results were ―. CPR beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 52.41% of the time in the same period. In the last calendar year CPR has Performed in-line its overall industry.
Next quarter’s sales forecast for CPR is €795.38M with a range of €761.62M to €850.10M. The previous quarter’s sales results were ―. CPR beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 52.41% of the time in the same period. In the last calendar year CPR has Performed in-line its overall industry.
CPR Stock Forecast FAQ
What is IT:CPR’s average 12-month price target, according to analysts?
Based on analyst ratings, Davide Campari-Milano SpA’s 12-month average price target is 7.41.
What is IT:CPR’s upside potential, based on the analysts’ average price target?
Davide Campari-Milano SpA has 29.32% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Davide Campari-Milano SpA a Buy, Sell or Hold?
Davide Campari-Milano SpA has a consensus rating of Moderate Buy, which is based on 5 buy ratings, 6 hold ratings and 0 sell ratings.
What is Davide Campari-Milano SpA’s share price target?
The average share price target for Davide Campari-Milano SpA is 7.41. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst share price target is €11.00 ,and the lowest forecast is €5.13. The average share price target represents 29.32% Increase from the current price of €5.73.
What do analysts say about Davide Campari-Milano SpA?
Davide Campari-Milano SpA’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
How can I buy shares of Davide Campari-Milano SpA?
To buy shares of IT:CPR, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.